Clinical trial
Safety and Dosing Evaluation of REG1 Anticoagulation System
NCT00113997 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00113997 |
|---|---|
| Title | Safety and Dosing Evaluation of REG1 Anticoagulation System |
| Official title | The Healthy Volunteer Evaluation of an Aptamer-RNA Target to Factor IXa |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | REG1 |
| Enrollment | 106 |
| Start date | Jun 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Jun 13, 2005 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: